Bruker Corp
BRKR39.840USD
+0.180+0.45%
Fechamento 04/29, 16:00（ET）Cotações atrasadas em 15 min
6.04BValor de mercado
53.43P/L TTM
Mais detalhes de Bruker Corp Empresa
Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Informações da empresa
Código da empresaBRKR
Nome da EmpresaBruker Corp
Data de listagemAug 04, 2000
Fundado em2000
CEODr. Burkhard A. Prause, Ph.D.
Número de funcionários11396
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 04
Endereço40 Manning Rd
CidadeBILLERICA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal01821-3915
Telefone19786633660
Sitehttps://www.bruker.com/
Código da empresaBRKR
Data de listagemAug 04, 2000
Fundado em2000
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.38M
+0.05%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
80.90K
-1.13%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
76.30K
-2.65%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
49.51K
-7.39%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
26.30K
-5.77%
Dr. Hermann Fritz Requardt, Ph.D.
Dr. Hermann Fritz Requardt, Ph.D.
Independent Director
Independent Director
23.15K
-3.83%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
23.15K
-3.83%
Ms. Adelene Q. Perkins
Ms. Adelene Q. Perkins
Independent Director
Independent Director
21.33K
-4.14%
Dr. Cynthia M. Friend, Ph.D.
Dr. Cynthia M. Friend, Ph.D.
Independent Director
Independent Director
13.95K
-6.19%
Ms. Bonnie H. Anderson
Ms. Bonnie H. Anderson
Independent Director
Independent Director
10.03K
-8.41%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.38M
+0.05%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
80.90K
-1.13%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
76.30K
-2.65%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
49.51K
-7.39%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
26.30K
-5.77%
Dr. Hermann Fritz Requardt, Ph.D.
Dr. Hermann Fritz Requardt, Ph.D.
Independent Director
Independent Director
23.15K
-3.83%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Product
2.76B
81.96%
Service and other revenue
607.20M
18.04%
Por RegiãoUSD
Nome
Receita
Proporção
United States
938.50M
27.88%
Europe
873.00M
25.93%
Asia Pacific
518.50M
15.40%
China
471.20M
14.00%
Germany
310.70M
9.23%
Other
254.50M
7.56%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Product
2.76B
81.96%
Service and other revenue
607.20M
18.04%
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Laukien (Frank H)
26.65%
Fidelity Management & Research Company LLC
8.39%
T. Rowe Price Investment Management, Inc.
8.18%
The Vanguard Group, Inc.
7.01%
BlackRock Institutional Trust Company, N.A.
6.62%
Other
43.16%
Estatísticas dos acionistas
Acionista
Proporção
Laukien (Frank H)
26.65%
Fidelity Management & Research Company LLC
8.39%
T. Rowe Price Investment Management, Inc.
8.18%
The Vanguard Group, Inc.
7.01%
BlackRock Institutional Trust Company, N.A.
6.62%
Other
43.16%
Tipo
Acionista
Proporção
Investment Advisor
46.69%
Individual Investor
31.98%
Investment Advisor/Hedge Fund
25.84%
Hedge Fund
6.13%
Pension Fund
1.33%
Bank and Trust
1.01%
Research Firm
0.91%
Sovereign Wealth Fund
0.77%
Family Office
0.05%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
858
174.15M
114.80%
+663.90K
2024Q4
874
174.12M
114.80%
+488.91K
2024Q3
832
169.17M
111.74%
-784.20K
2024Q2
803
166.71M
111.27%
+3.25M
2024Q1
787
160.55M
116.07%
-746.16K
2023Q4
764
159.55M
114.90%
-2.81M
2023Q3
739
159.71M
108.74%
-10.40M
2023Q2
728
167.57M
114.19%
+11.26M
2023Q1
709
153.65M
104.63%
-3.11M
2022Q4
708
153.72M
104.51%
-4.97M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Laukien (Frank H)
40.36M
26.6%
+20.00K
+0.05%
Feb 18, 2025
Fidelity Management & Research Company LLC
12.71M
8.38%
-276.55K
-2.13%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
12.39M
8.17%
-642.15K
-4.93%
Dec 31, 2024
The Vanguard Group, Inc.
10.63M
7.01%
-47.32K
-0.44%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
10.02M
6.61%
+111.64K
+1.13%
Dec 31, 2024
Pallas Capital Advisors LLC
9.48M
6.25%
-1.39K
-0.01%
Dec 31, 2024
Laukien (Joerg C)
7.52M
4.95%
--
--
Apr 01, 2024
The London Company of Virginia, LLC
4.19M
2.76%
+1.84M
+78.43%
Dec 31, 2024
State Street Global Advisors (US)
3.79M
2.5%
+166.91K
+4.60%
Dec 31, 2024
MFS Investment Management
2.86M
1.88%
-2.47M
-46.33%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
ProShares Nanotechnology ETF
3.68%
First Trust NYSE Arca Biotechnology Index Fund
2.42%
Janus Henderson Small/Mid Cap Growth Alpha ETF
1.77%
SPDR S&P Kensho Future Security ETF
1.14%
Janus Henderson US Sustainable Equity ETF
0.69%
SPDR S&P Kensho New Economies Composite ETF
0.63%
Franklin Genomic Advancements ETF
0.55%
Invesco NASDAQ Future Gen 200 ETF
0.42%
iShares Biotechnology ETF
0.4%
First Trust Health Care Alphadex Fund
0.33%
Ver Mais
ProShares Nanotechnology ETF
Proporção3.68%
First Trust NYSE Arca Biotechnology Index Fund
Proporção2.42%
Janus Henderson Small/Mid Cap Growth Alpha ETF
Proporção1.77%
SPDR S&P Kensho Future Security ETF
Proporção1.14%
Janus Henderson US Sustainable Equity ETF
Proporção0.69%
SPDR S&P Kensho New Economies Composite ETF
Proporção0.63%
Franklin Genomic Advancements ETF
Proporção0.55%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.42%
iShares Biotechnology ETF
Proporção0.4%
First Trust Health Care Alphadex Fund
Proporção0.33%
Dividendo
Um total de
138.20M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Feb 21, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 28, 2025
Mar 17, 2025
Nov 18, 2024
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024
Dec 02, 2024
Dec 16, 2024
Dec 02, 2024
Aug 14, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024
Sep 02, 2024
Sep 16, 2024
Aug 30, 2024
May 15, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024
Jun 03, 2024
Jun 17, 2024
Jun 03, 2024
Feb 16, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 20, 2023
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
Aug 14, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 15, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 15, 2023
Aug 31, 2023
May 15, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 16, 2023 going ex on May 31, 2023
Jun 01, 2023
Jun 16, 2023
May 31, 2023
Feb 17, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 17, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 17, 2023
Feb 28, 2023
Nov 11, 2022
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2022 going ex on Nov 30, 2022
Dec 01, 2022
Dec 16, 2022
Nov 30, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados